Blog

Featured

Stem Cell Therapy for Erectile Dysfunction: A Patient’s Guide to the 2026 Evidence

Diabetic ED, post-prostatectomy ED, PDE5 non-responders — here’s what 2026 trials and clinical experience show for stem cell therapy: who is a candidate, what the procedure looks like, what it costs, and what to expect.

Aug 22, 2026

Featured

Is Stem Cell Therapy Legal and Safe in Thailand? (2026 Patient Guide)

Is Stem Cell Therapy Legal and Safe in Thailand? For international patients considering regenerative treatments, traveling abroad for stem cell therapy brings both immense hope and important practical questions. As medic…

Aug 13, 2026

Featured

How Much Does Stem Cell Therapy Cost in 2026? A Patient’s Realistic Guide

Stem cell therapy prices range from $2,000 to $100,000 depending on where you go. Here’s what actually drives the cost, what’s included, and how Thailand compares to the US, Australia, and Europe in 2026.

Jun 25, 2026

Featured

Stem Cell Therapy Cost in Thailand — Complete Price Guide 2026

How Much Does Stem Cell Therapy Cost in Thailand? Stem cell therapy in Thailand costs $3,500–$40,000 USD, depending on the treatment type, number of cells used, and protocol complexity. This is 50–70% less than equivalen…

Jun 6, 2026

Stem Cell Therapy: Thailand vs USA and Europe in 2026

Cost gaps, regulatory trade-offs, and wait times compared honestly — including the three areas where the USA and Europe are genuinely the better choice.

Nov 11, 2026

Stem Cell Therapy for Diabetic Peripheral Neuropathy: Pilot Data, Schwann Cell Mechanisms, and the Exosome Shift

Two 2026 systematic reviews, a Schwann cell mechanism study, and the first powered RCT in diabetic peripheral neuropathy — what clinicians need to know about MSC and exosome therapy for DPN.

Nov 10, 2026

Thailand Medical Visa Guide for Stem Cell Treatment (2026)

DTV, tourist visa or LTR: which entry fits a stem cell protocol in Bangkok, what the clinic letter must say, and how long you actually need to stay.

Nov 9, 2026

MSC Therapy for Multiple Sclerosis: 2026 RCT Data & Meta-Analysis

Reviewing the latest RCTs (SMART-MS) and meta-analyses on MSC therapy for progressive multiple sclerosis, including efficacy and safety data.

Nov 9, 2026

Mesenchymal Stem Cell Therapy in Cervical Cancer: What the 2026 Evidence Shows

A 2026 systematic review found 14 studies of mesenchymal stem cells in cervical cancer, with contradictory results and no study controlling for HPV genotype. Here is what the evidence actually shows.

Nov 9, 2026

Glycocalyx-Edited MSC Therapy for Advanced Osteoporosis: First-in-Human Trial Results Published in Cell

The first-in-human trial of glycocalyx-edited autologous MSCs shows that engineering bone homing via sLeX expression reduces fragility fractures and increases bone density in advanced osteoporosis patients, with five-plu…

Nov 2, 2026

MSC Therapy for Traumatic Brain Injury: Phase 1/2a Results Show Reduced Brain Inflammation and Clinical Improvement

The Cox et al. Phase 1/2a trial in Brain (2026) demonstrates that autologous adipose-derived MSCs reduce brain immune cell density and improve depression, fatigue, and pain in chronic TBI patients.

Oct 28, 2026

Stem Cell Therapy for Hair Loss in 2026: What the Science Actually Shows

From MSC secretome to exosome injections and next-gen PRP alternatives, here is what 2026 research says about regenerative hair loss treatments — and who they work best for.

Oct 24, 2026